Clinical Trial Update: Retinal Protective Effects of Novel Finerenone in Patients With Chronic Kidney Disease [Phase 4]

View source ↗

Summary

Phase 4 trial studying whether finerenone can protect the retina in patients with chronic kidney disease; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Kerendia (finerenone)

Snippet

Sponsor: Alexandria University | Conditions: Retinal Nerve Fiber Layer Thickness, Chronic Kidney Disease | Phase 4 | Status: NOT_YET_RECRUITING